F. Verroust

703 citations
19 papers · 421 indexed · h-index 8

F. Verroust

18 papers receiving 383 citations

Peers

F. Verroust
Comparison fields: 5 of 55
  • Virology 157
  • Hematology 158
  • Infectious Diseases 128
  • Biochemistry 39
  • Genetics 41
Replace Mitsuyasu Rt with:
Mitsuyasu Rt United States
DB Brettler United States
M. V. Ragni United States
Glaspy Ja United States
H Weigel Netherlands
C. Rabian France
J Fitness United Kingdom
S. Owen United Kingdom
K.‐A. Kreuzer Germany
FA Bontempo United States
F. Verroust relative to Mitsuyasu Rt United States Mitsuyasu Rt's profile →
Citations per field
00.5×1.5×1.9×
Mitsuyasu Rt · 1×
Citations per year

Countries citing papers authored by F. Verroust

Since Specialization
Citations

This map shows the geographic impact of F. Verroust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Verroust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Verroust more than expected).

Fields of papers citing papers by F. Verroust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Verroust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Verroust. The network helps show where F. Verroust may publish in the future.

Co-authorship network

The 25 scholars most cited alongside F. Verroust, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F. Verroust Line = papers co-authored together F. Verroust links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 199314
2 19924
3
Antibody to hepatitis C (anti C 100-3) in French hemophiliacs.
19919
4 19901
5 19901
6 19901
7 199040
8
Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.
19884
9 1987194
10 198722
11 19842
12 19840
13 19823
14 19826
15
Circulating immune complexes and complement levels in hemophilic children.
19814
16 198053
17 19792
18 197412
19 197449

About F. Verroust

F. Verroust is a scholar working on Hematology, Hepatology and Virology, having authored 19 papers that have together received 421 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (14 papers), Chronic Myeloid Leukemia Treatments (8 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), Platelet Disorders and Treatments (4 papers), Blood groups and transfusion (3 papers), Hepatitis C virus research (3 papers), Hepatitis B Virus Studies (2 papers) and HIV Research and Treatment (1 paper). The work is most often cited by research in Virology (157 citations), Hematology (158 citations) and Infectious Diseases (128 citations). F. Verroust has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Y. Laurian, J P Allain, David B. Senn, C. Gazengel, M J Larrieu, Deborah A. Paul, J P Soulier, Jean‐Pierre Allain, F E Preston and PB Kernoff. Their work appears in journals such as Vox Sanguinis, New England Journal of Medicine, Thrombosis and Haemostasis, Blood and Obstetrical & Gynecological Survey.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026